Last reviewed · How we verify
Blood and biopsy sampling — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Blood and biopsy sampling (Blood and biopsy sampling) — Hospices Civils de Lyon.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood and biopsy sampling TARGET | Blood and biopsy sampling | Hospices Civils de Lyon | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood and biopsy sampling CI watch — RSS
- Blood and biopsy sampling CI watch — Atom
- Blood and biopsy sampling CI watch — JSON
- Blood and biopsy sampling alone — RSS
Cite this brief
Drug Landscape (2026). Blood and biopsy sampling — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-and-biopsy-sampling. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab